Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 3 7Phase 2/3 6Phase 1/2 4Phase EARLY_PHASE1 3Phase NA 1Phase 4 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 9Gynecologic 3Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Ovarian Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Endometrial Endometrioid Adenocarcinoma 1Breast Neoplasms 1

Interventions

olaparib 6Specimen Handling 5Paclitaxel 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 4Carboplatin 4pembrolizumab 3fludarabine 3X-Rays 3Taxes 3Metformin 3Letrozole 3Fluorodeoxyglucose F18 3Biopsy 3Aspirin 3niraparib 2Tirzepatide 2Radiotherapy 2Propranolol 2Platinum 2Pafolacianine 2Oncolytic Virotherapy 2Hysterectomy 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorescein 2Drug Therapy 2Doxorubicin 2Cytoreduction Surgical Procedures 2Cisplatin 21,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Letrozole × Gynecologic × Clear all
NCT04049227 2025-10-20

Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

Northwestern University

Phase EARLY_PHASE1 Completed
27 enrolled
Gynecologic

Endometrial Endometrioid Adenocarcinoma

NCT03378297 2024-10-30

IMPACT

Haukeland University Hospital

Phase EARLY_PHASE1 Completed
26 enrolled
Gynecologic

Ovarian Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡